Bacteriological Profile and Antimicrobial Susceptibility Patterns of Gram-Negative Bloodstream Infection and Risk Factors Associated with Mortality and Drug Resistance: A Retrospective Study from Shanxi, China

被引:10
作者
Shi, Nan [1 ,2 ]
Kang, Jianbang [2 ]
Wang, Shuyun [2 ]
Song, Yan [2 ]
Yin, Donghong [2 ]
Li, Xiaoxia [2 ]
Guo, Qian [2 ]
Duan, Jinju [2 ]
Zhang, Shuqiu [1 ]
机构
[1] Shanxi Med Univ, Dept Pharm, Taiyuan, Shanxi, Peoples R China
[2] Shanxi Med Univ, Dept Pharm, Hosp 2, Taiyuan, Shanxi, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2022年 / 15卷
关键词
gram -negative bloodstream infection; epidemiology; risk prediction model; MDR; ESBL; carbapenem resistance; CRITICALLY-ILL PATIENTS; ENTEROBACTERIACEAE; STRATIFICATION; EPIDEMIOLOGY; MALIGNANCIES; BACTEREMIA; PREVENTION;
D O I
10.2147/IDR.S370326
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: The aim of this study was to analyze the epidemiological of gram-negative bloodstream infection (GNBSI) and establish a risk prediction model for mortality and acquiring multidrug resistant (MDR), the extended spectrum beta-lactamases (ESBLs) producing and carbapenem-resistant (CR) GNBSI. Methods: This retrospective study covered five years from January 2015 to December 2019. Data were obtained from Hospital Information System (HIS) and microbiology department records. The risk factors for mortality and acquiring MDR, ESBLs-producing and CR GNBSI were analyzed by univariable and multivariable analysis. Results: A total of 1018 GNBSI cases were collected. A majority of GNBSI patients were in hematology ward (23.77%). There were 38.61% patients who were assigned in the 41-60 age group. Escherichia coli was the most common gram-negative organism (49.90%). Among isolates of GNBSI, 40.47% were found to be MDR strains, 34.09% were found to be ESBLs-producing strains and 7.06% were found to be CR strains. Escherichia coli was the most common MDR (71.36%) and ESBLs-producing strain (77.81%). Acinetobacter baumannii was the most common CR isolate (46.15%). Multivariate analysis indicated that diabetes mellitus, solid organ tumor, non-fermentative bacteria, MDR strain, central venous cannula, urinary catheter, therapy with carbapenems or tigecycline prior 30 days of infection were independent mortality risk factors for GNBSIs. Over all, therapy with tigecycline prior 30 days of infection was the mutual predictor for mortality of GNBSI, acquiring MDR, ESBLs-producing and CR GNBSI (OR, 8.221, OR, 3.963, OR, 3.588, OR, 9.222, respectively, all p < 0.001). Conclusion: Collectively, our study implies that patients who were diagnosed as GNBSI had a younger age. Therapy with tigecycline was the mutual and paramount predictor for mortality of GNBSI, acquiring MDR, ESBLs-producing and CR GNBSI. Our investigation had provided a theoretical basis for the use of antibiotics and prevention and control of hospital infection in our region.
引用
收藏
页码:3561 / 3578
页数:18
相关论文
共 55 条
  • [1] Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy
    Al-Hasan, Majdi N.
    [J]. ANTIBIOTICS-BASEL, 2020, 9 (12):
  • [2] Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance
    Amanati, Ali
    Sajedianfard, Sarvin
    Khajeh, Somayeh
    Ghasempour, Shabnam
    Mehrangiz, Salma
    Nematolahi, Samane
    Shahhosein, Zahra
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [3] Central venous catheter associated blood stream infections (CVC-BSIs) in the non-intensive care settings: Epidemiology, microbiology and outcomes
    Aminzadeh, Z.
    Simpson, P.
    Athan, E.
    [J]. INFECTION DISEASE & HEALTH, 2019, 24 (04) : 222 - 228
  • [4] Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
    Bassetti, Matteo
    Vena, Antonio
    Sepulcri, Chiara
    Giacobbe, Daniele Roberto
    Peghin, Maddalena
    [J]. ANTIBIOTICS-BASEL, 2020, 9 (09): : 1 - 18
  • [5] Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections
    Bassetti, Matteo
    Carnelutti, Alessia
    Peghin, Maddalena
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2017, 15 (01) : 55 - 65
  • [6] Prevention of Central Line-Associated Bloodstream Infections
    Bell, Taison
    O'Grady, Naomi P.
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2017, 31 (03) : 551 - +
  • [7] Plasmodium bergheisporozoites in nonreplicative vacuole are eliminated by aPI3P-mediated autophagy-independent pathway
    Bindschedler, Annina
    Wacker, Rahel
    Egli, Jessica
    Eickel, Nina
    Schmuckli-Maurer, Jacqueline
    Franke-Fayard, Blandine M.
    Janse, Chris J.
    Heussler, Volker T.
    [J]. CELLULAR MICROBIOLOGY, 2021, 23 (01)
  • [8] Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: Clinical outcome and length of hospitalization
    Blot, S
    Vandewoude, K
    De Bacquer, D
    Colardyn, F
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) : 1600 - 1606
  • [9] Invasion of vaginal epithelial cells by uropathogenic Escherichia coli
    Brannon, John R.
    Dunigan, Taryn L.
    Beebout, Connor J.
    Ross, Tamia
    Wiebe, Michelle A.
    Reynolds, William S.
    Hadjifrangiskou, Maria
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [10] Stratification of the Impact of Inappropriate Empirical Antimicrobial Therapy for Gram-Negative Bloodstream Infections by Predicted Prognosis
    Cain, Sarah E.
    Kohn, Joseph
    Bookstaver, P. Brandon
    Albrecht, Helmut
    Al-Hasan, Majdi N.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 245 - 250